{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:08:12Z","timestamp":1793624892798,"version":"4.5.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007765","name":"Shenyang Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017439","name":"Liaoning Province Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017439","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012467","name":"Distinguished Professor of Liaoning Province","doi-asserted-by":"publisher","award":["28020"],"award-info":[{"award-number":["28020"]}],"id":[{"id":"10.13039\/501100012467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaut.2022.102892","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T21:13:04Z","timestamp":1661375584000},"page":"102892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neuropsychiatric lupus erythematosus: Focusing on autoantibodies"],"prefix":"10.1016","volume":"132","author":[{"given":"Jianing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2800-7947","authenticated-orcid":false,"given":"Pingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102892_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/annrheumdis-2019-216150","article-title":"Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach","volume":"3","author":"Hanly","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 5","key":"10.1016\/j.jaut.2022.102892_bib2","doi-asserted-by":"crossref","first-page":"v52","DOI":"10.1093\/rheumatology\/keaa404","article-title":"The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?","author":"Govoni","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0961203307085671","article-title":"Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients","volume":"2","author":"Zhou","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.22305","article-title":"Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study","volume":"1","author":"Hanly","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"1","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-019-1971-2","article-title":"Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus","volume":"1","author":"Jiang","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/14397595.2019.1589912","article-title":"Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: a real world single center study","volume":"2","author":"Li","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.berh.2010.10.006","article-title":"Systemic lupus erythematosus","volume":"6","author":"O'Neill","year":"2010","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib9","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1177\/0961203310373106","article-title":"Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China","volume":"11","author":"Shen","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib10","first-page":"599","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"4","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00234-016-1688-8","article-title":"Evaluation of white matter integrity in systemic lupus erythematosus by diffusion tensor magnetic resonance imaging: a study using tract-based spatial statistics","volume":"8","author":"Correa","year":"2016","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jaut.2022.102892_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11065-008-9061-2","article-title":"Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis","volume":"2","author":"Benedict","year":"2008","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/key282","article-title":"Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus","volume":"5","author":"Probstel","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2377-12-152","article-title":"Posterior reversible encephalopathy syndrome could be an underestimated variant of \u201creversible neurological deficits\u201d in Systemic Lupus Erythematosus","author":"Liu","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.01.011","article-title":"Demyelinating syndrome in SLE encompasses different subtypes: do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis","volume":"3","author":"Piga","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.889613","article-title":"Demyelinating syndromes in systemic lupus erythematosus: data from the \u201cAttikon\u201d lupus cohort","author":"Nikolopoulos","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib17","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: a review","volume":"4","author":"Carrion-Barbera","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib18","article-title":"Posterior reversible encephalopathy syndrome: a neuropsychiatric manifestation of systemic lupus erythematosus","volume":"2","author":"Valdez-Lopez","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib19","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1097\/RHU.0000000000001470","article-title":"Rheumatic diseases associated with posterior reversible encephalopathy syndrome","volume":"8","author":"Manadan","year":"2021","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0885066610393634","article-title":"Posterior reversible encephalopathy syndrome","volume":"1","author":"Staykov","year":"2012","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.jaut.2022.102892_bib21","article-title":"Delayed presentation of posterior reversible encephalopathy syndrome in the setting of serotonin-norepinephrine reuptake inhibitors","volume":"2","author":"Bhutada","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2022.102892_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","article-title":"Systemic lupus erythematosus and ocular involvement: an overview","volume":"2","author":"Dammacco","year":"2018","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12969-022-00688-5","article-title":"Pseudotumor cerebri syndrome in children with systemic lupus erythematosus: case series and review","volume":"1","author":"Moussa","year":"2022","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.jaut.2022.102892_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0961203311435267","article-title":"Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience","volume":"5","author":"Kim","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib25","doi-asserted-by":"crossref","first-page":"e3347","DOI":"10.1371\/journal.pone.0003347","article-title":"Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis","volume":"10","author":"Fragoso-Loyo","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102892_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.autrev.2017.05.011","article-title":"Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a single centre","volume":"7","author":"Toledano","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.41070","article-title":"Peripheral nervous system disease in systemic lupus erythematosus: results from an international inception cohort study","volume":"1","author":"Hanly","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31138\/mjr.30.1.7","article-title":"Cerebrovascular events in systemic lupus erythematosus: diagnosis and management","volume":"1","author":"Nikolopoulos","year":"2019","journal-title":"Mediterr. J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"3","author":"Vina","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib30","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in association with concomitant diseases: identification and management","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0404.1991.tb03971.x","article-title":"Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"6","author":"Sindern","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2022.102892_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.610585","article-title":"Immune axonal neuropathies associated with systemic autoimmune rheumatic diseases","author":"Tulba","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2022.102892_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0961203317691373","article-title":"Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches","volume":"5","author":"Postal","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0049-0172(79)80009-8","article-title":"Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977","volume":"3","author":"Ellis","year":"1979","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"1","author":"Cohen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib36","article-title":"Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China","author":"Zhang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2022.102892_bib37","first-page":"1003","article-title":"Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus","volume":"6","author":"Hirohata","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib38","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"2","author":"Hirohata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/096120339400300211","article-title":"Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement","volume":"2","author":"Mevorach","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"6","author":"Diamond","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/art.38900","article-title":"Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice","volume":"1","author":"Bravo-Zehnder","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"3","author":"Huerta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102892_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they Be used as biomarkers for the differential diagnosis of this disease?","author":"Manca","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semarthrit.2018.11.005","article-title":"Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: case series and review of literature","volume":"1","author":"Kello","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib45","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"5","author":"Sanna","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"2","author":"Ho","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib47","first-page":"4353","article-title":"Role of TLR4 in antibeta2glycoprotein induced activation of peritoneal macrophages and vascular endothelial cells in mice","volume":"5","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jaut.2022.102892_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2018.07.021","article-title":"Development of a thrombin generation test in cultured endothelial cells: evaluation of the prothrombotic effects of antiphospholipid antibodies","author":"Billoir","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jaut.2022.102892_bib49","article-title":"Antibeta2GPI\/beta2GPI induces neutrophil pyroptosis and thereby enhances ICAM1 and IL8 expression in endothelial cells","volume":"5","author":"Luo","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu409oa","article-title":"Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer","volume":"6","author":"Shoenfeld","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2014.03.003","article-title":"Stepwise recruitment of transcellular and paracellular pathways underlies blood-brain barrier breakdown in stroke","volume":"3","author":"Knowland","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2022.102892_bib52","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10067-008-0921-1","article-title":"Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus","volume":"11","author":"Abdel-Nasser","year":"2008","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib53","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"3","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib54","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar2184","article-title":"Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"3","author":"Hirohata","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib55","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/art.39111","article-title":"Mood disorders in systemic lupus erythematosus: results from an international inception cohort study","volume":"7","author":"Hanly","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.162.2.459","article-title":"Lupus autoantibodies target ribosomal P proteins","volume":"2","author":"Elkon","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/art.22419","article-title":"Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system","volume":"3","author":"Katzav","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"1\u20132","author":"Katzav","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-020-1716-9","article-title":"Neuroprotective effect of microglia against impairments of auditory steady-state response induced by anti-P IgG from SLE patients in naive mice","volume":"1","author":"Wang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102892_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clim.2008.10.010","article-title":"Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship","volume":"3","author":"Moscavitch","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaut.2008.09.002","article-title":"Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression)","volume":"4","author":"Katzav","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102892_bib62","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"13","author":"Matus","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib63","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/art.39081","article-title":"Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model","volume":"6","author":"Segovia-Miranda","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577648","article-title":"Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies","author":"Zhao","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib65","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12915-020-00877-2","article-title":"Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG","volume":"1","author":"Espinoza","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.jaut.2022.102892_bib66","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.159.4.2033","article-title":"Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture","volume":"4","author":"Koscec","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib67","first-page":"12","article-title":"Anti-ribosomal and \u2018P-peptide\u2019-specific autoantibodies bind to T lymphocytes","volume":"1","author":"Stafford","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/s10165-010-0354-y","article-title":"Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes","volume":"1","author":"Nagai","year":"2011","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib69","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"11","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0961203307078224","article-title":"Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives","volume":"5","author":"Steup-Beekman","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib71","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1177\/0961203320954918","article-title":"Association of anti-NR2 and U1RNP antibodies with neurotoxic inflammatory mediators in cerebrospinal fluid from patients with neuropsychiatric systemic lupus erythematosus","volume":"13","author":"Kondo-Ishikawa","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib72","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"1","author":"Chan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2022.102892_bib73","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"52","author":"Kowal","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102892_bib74","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"10","author":"Nestor","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"2","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102892_bib76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"3","author":"Asgari","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2022.102892_bib77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.40356","article-title":"Understanding the antibody repertoire in neuropsychiatric systemic lupus erythematosus and neuromyelitis optica spectrum disorder: do they share common targets?","volume":"2","author":"Mader","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib78","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bpa.12085","article-title":"Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO","volume":"6","author":"Verkman","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2022.102892_bib79","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","article-title":"The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody","volume":"5","author":"Hoftberger","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2022.102892_bib80","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/WCO.0000000000000813","article-title":"Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases","volume":"3","author":"Mader","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica","volume":"1","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2022.102892_bib82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","article-title":"Mechanisms for lesion localization in neuromyelitis optica spectrum disorders","volume":"3","author":"Bradl","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib83","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.0000000000001126","article-title":"Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions","volume":"2","author":"Popescu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102892_bib84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2022.102892_bib85","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","article-title":"Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica","volume":"5","author":"Ratelade","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2022.102892_bib86","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-018-1950-8","article-title":"Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat","volume":"3","author":"Hillebrand","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jaut.2022.102892_bib87","article-title":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica","volume":"397","author":"Shimizu","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib88","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"3","author":"Linington","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2022.102892_bib89","first-page":"245","article-title":"Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation","volume":"2","author":"Piddlesden","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib90","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"2","author":"Piddlesden","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2022.102892_bib91","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1073\/pnas.1519608113","article-title":"Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease","volume":"12","author":"Flach","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102892_bib92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2011.09.005","article-title":"Antibody response in MOG(35-55) induced EAE","author":"Lalive","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib93","doi-asserted-by":"crossref","first-page":"R366","DOI":"10.1186\/ar1198","article-title":"Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies","volume":"4","author":"Conti","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002960000060","article-title":"Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus","volume":"1","author":"Song","year":"2000","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102892_bib95","first-page":"173","article-title":"Study of anti-endothelial cell antibodies in SLE patients with acute ischemic stroke","volume":"2","author":"Cojocaru","year":"2010","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib96","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00296-022-05104-5","article-title":"The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study","volume":"5","author":"Cieslik","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102892_bib97","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/39.10.1114","article-title":"Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen","volume":"10","author":"Frampton","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib98","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/art.20564","article-title":"Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients","volume":"10","author":"Dieude","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib99","doi-asserted-by":"crossref","first-page":"R896","DOI":"10.1186\/ar1759","article-title":"Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations","volume":"4","author":"Margutti","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intimm\/13.3.349","article-title":"Human monoclonal anti-endothelial cell IgG-derived from a systemic lupus erythematosus patient binds and activates human endothelium in vitro","volume":"3","author":"Yazici","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/096120339900800603","article-title":"Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro","volume":"6","author":"Del Papa","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib102","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/rheumatology\/ket481","article-title":"Identification of novel autoantibodies to GABA(B) receptors in patients with neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Tsuchiya","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib103","first-page":"135","article-title":"Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE","volume":"1","author":"Galeazzi","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib104","doi-asserted-by":"crossref","first-page":"185","DOI":"10.17219\/acem\/76711","article-title":"Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus","volume":"2","author":"Szmyrka","year":"2019","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jcla.20248","article-title":"Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus","volume":"4","author":"Sun","year":"2008","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jaut.2022.102892_bib106","article-title":"Elevation of serum anti-glucose-regulated protein 78 antibodies in neuropsychiatric systemic lupus erythematosus","volume":"1","author":"Matsueda","year":"2018","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib107","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.39750","article-title":"Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases","volume":"11","author":"Delunardo","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108980","article-title":"Measurement of anti-suprabasin antibodies, multiple cytokines and chemokines as potential predictive biomarkers for neuropsychiatric systemic lupus erythematosus","author":"Hoang","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib109","first-page":"474","article-title":"The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Li","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/14397595.2015.1123345","article-title":"Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus","volume":"4","author":"Yamada","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib111","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13075-014-0450-z","article-title":"Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus","volume":"5","author":"Hirohata","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib112","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"12","author":"Mikdashi","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib113","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s10067-017-3653-2","article-title":"Association of anti-triosephosphate isomerase antibodies with aseptic meningitis in patients with neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Sato","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib114","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1191\/0961203303lu503oa","article-title":"Endothelium and the brain in CNS lupus","volume":"12","author":"Meroni","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib115","article-title":"The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: a narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines","volume":"8","author":"Deijns","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763065","article-title":"CXCL13 neutralization attenuates neuropsychiatric manifestations in lupus-prone mice","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib117","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/annrheumdis-2020-218004","article-title":"Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment","volume":"12","author":"Kamintsky","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib118","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s10067-016-3339-1","article-title":"Anti-NR2 antibodies, blood-brain barrier, and cognitive dysfunction","volume":"12","author":"Gulati","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib119","article-title":"Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus","volume":"10","author":"Asano","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102892_bib120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2015.03.005","article-title":"TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL\/lpr mice","author":"Wen","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102892_bib121","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.09-138834","article-title":"C5a alters blood-brain barrier integrity in experimental lupus","volume":"6","author":"Jacob","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jaut.2022.102892_bib122","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/imm.12619","article-title":"C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus","volume":"4","author":"Mahajan","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2022.102892_bib123","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.02.011","article-title":"Inhibition of C5a receptor alleviates experimental CNS lupus","volume":"1\u20132","author":"Jacob","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/s10165-012-0624-y","article-title":"Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study","volume":"1","author":"Katsumata","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","article-title":"Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity","volume":"9","author":"Li","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib126","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"1","author":"Haruwaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2022.102892_bib127","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","author":"Jackson","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2022.102892_bib128","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10067-003-0796-0","article-title":"Apolipoprotein E polymorphism in patients with neuropsychiatric SLE","volume":"2","author":"Pullmann","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib129","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.41213","article-title":"Role of low-density lipoprotein in early vascular aging associated with systemic lupus erythematosus","volume":"6","author":"Chan","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2018.03.001","article-title":"Mechanisms of neuropsychiatric lupus: the relative roles of the blood-cerebrospinal fluid barrier versus blood-brain barrier","author":"Gelb","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102892_bib131","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2741\/1241","article-title":"Signaling the brain in systemic inflammation: role of sensory circumventricular organs","author":"Roth","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jaut.2022.102892_bib132","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.3389\/fimmu.2018.02189","article-title":"Neuropsychiatric systemic lupus erythematosus is dependent on sphingosine-1-phosphate signaling","author":"Mike","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib133","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13075-017-1500-0","article-title":"Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus","volume":"1","author":"Chalmers","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib134","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.devcel.2020.09.020","article-title":"Inflammation of the embryonic choroid plexus barrier following maternal immune activation","volume":"5","author":"Cui","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jaut.2022.102892_bib135","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2020.12.040","article-title":"Functional characterization of the dural sinuses as a neuroimmune interface","volume":"4","author":"Rustenhoven","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2022.102892_bib136","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/1073858417691030","article-title":"The glymphatic pathway: waste removal from the CNS via cerebrospinal fluid transport","volume":"5","author":"Benveniste","year":"2017","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jaut.2022.102892_bib137","first-page":"6553","article-title":"Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders","author":"Brioschi","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaut.2022.102892_bib138","article-title":"Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma","volume":"6553","author":"Cugurra","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaut.2022.102892_bib139","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41590-019-0344-y","article-title":"Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity","volume":"4","author":"Rua","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib140","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.immuni.2021.09.016","article-title":"Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges","volume":"12","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102892_bib141","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41593-021-00880-y","article-title":"Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges","volume":"9","author":"Schafflick","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2022.102892_bib142","article-title":"Bcl6 controls meningeal Th17-B cell interaction in murine neuroinflammation","volume":"36","author":"Hartlehnert","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2022.102892_bib143","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/s41593-022-01108-3","article-title":"Distinct roles of the meningeal layers in CNS autoimmunity","volume":"7","author":"Merlini","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2022.102892_bib144","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41593-022-01029-1","article-title":"Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels","volume":"5","author":"Mazzitelli","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2022.102892_bib145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41593-022-01060-2","article-title":"Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis","volume":"5","author":"Pulous","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jaut.2022.102892_bib146","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1479-5876-11-107","article-title":"Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer","author":"Yang","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib147","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"7560","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2022.102892_bib148","article-title":"The blood-CSF-brain route of neurological disease: the indirect pathway into the brain","volume":"4","author":"Cousins","year":"2022","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jaut.2022.102892_bib149","first-page":"F835","article-title":"Drainage of interstitial fluid from different regions of rat brain","volume":"6 Pt 2","author":"Szentistvanyi","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jaut.2022.102892_bib150","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.3899\/jrheum.090027","article-title":"Onset of cognitive dysfunction in systemic lupus erythematosus and selective involvement of the choroid plexus","volume":"11","author":"Amaro","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib151","first-page":"387","article-title":"Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms","volume":"2","author":"Duprez","year":"2001","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib152","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2003.10.052","article-title":"B and T cells in the brains of autoimmune mice","volume":"1\u20132","author":"Zameer","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib153","article-title":"Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus","volume":"11","author":"Stock","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2022.102892_bib154","article-title":"B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies","volume":"1","author":"Schlosser","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jaut.2022.102892_bib155","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3389\/fimmu.2018.01536","article-title":"Unexpected help: follicular regulatory T cells in the germinal center","author":"Xie","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib156","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2018.00487","article-title":"A distinct T follicular helper cell subset infiltrates the brain in murine neuropsychiatric lupus","author":"Jain","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib157","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3389\/fimmu.2020.01476","article-title":"The T cell receptor repertoire in neuropsychiatric systemic lupus erythematosus","author":"Moore","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/art.42252","article-title":"Choroid plexus-infiltrating T cells drive murine neuropsychiatric lupus","author":"Moore","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib159","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","article-title":"FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus","author":"Shi","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102892_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576994","article-title":"Intracerebroventricular administration of lupus serum induces microglia activation and leukocyte adhesion in the cerebromicrovasculature of mice","author":"Wang","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2022.102892_bib161","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"5","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2022.102892_bib162","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","article-title":"Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies","volume":"1","author":"Lopes","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2022.102892_bib163","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/brain\/awab446","article-title":"Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state","volume":"3","author":"Smajic","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2022.102892_bib164","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2020.00230","article-title":"A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus","author":"Makinde","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13075-019-2067-8","article-title":"Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice","volume":"1","author":"Nomura","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib166","article-title":"Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer's disease","author":"Xu","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jaut.2022.102892_bib167","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12974-020-02003-z","article-title":"Microglial responses to peripheral type 1 interferon","volume":"1","author":"Aw","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jaut.2022.102892_bib168","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41392-021-00867-y","article-title":"Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus","volume":"1","author":"Han","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib169","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"6","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2022.102892_bib170","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"7701","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2022.102892_bib171","article-title":"Rapamycin modulates the proinflammatory memory-like response of microglia induced by BAFF","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib172","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2015.12.017","article-title":"Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice","author":"Wen","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2022.102892_bib173","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"1","author":"Wright","year":"2020","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.jaut.2022.102892_bib174","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3892\/etm.2017.4862","article-title":"Elevated levels of soluble fractalkine and increased expression of CX3CR1 in neuropsychiatric systemic lupus erythematosus","volume":"4","author":"Guo","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib175","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"4","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib176","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","article-title":"Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms","volume":"4","author":"George-Chandy","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib177","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/cmi.2016.47","article-title":"Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus","volume":"10","author":"Zhao","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13075-019-1985-9","article-title":"Interferon-alpha exacerbates neuropsychiatric phenotypes in lupus-prone mice","volume":"1","author":"Zeng","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2022.102892_bib179","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12967-019-02175-0","article-title":"Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor","volume":"1","author":"Yang","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/09612033211069853","article-title":"Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders","volume":"2","author":"Liang","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib181","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/84219","article-title":"Lymphocyte traffic control by chemokines","volume":"2","author":"Moser","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib182","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.7150\/thno.72756","article-title":"Eucommiae cortex polysaccharides mitigate obesogenic diet-induced cognitive and social dysfunction via modulation of gut microbiota and tryptophan metabolism","volume":"8","author":"Sun","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jaut.2022.102892_bib183","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2015.06.002","article-title":"Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity","volume":"6","author":"Gallo","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2022.102892_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2022.06.003","article-title":"Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis","author":"Luo","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.jaut.2022.102892_bib185","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/art.41511","article-title":"An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus","volume":"2","author":"Chen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib186","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2020.00282","article-title":"Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases","author":"Jiao","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib187","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41586-020-2886-4","article-title":"Gut-educated IgA plasma cells defend the meningeal venous sinuses","volume":"7834","author":"Fitzpatrick","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2022.102892_bib188","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes","volume":"7846","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2022.102892_bib189","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-022-00955-3","article-title":"Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers","author":"Carloni","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2022.102892_bib190","article-title":"The gut-meningeal immune axis: priming brain defense against the most likely invaders","volume":"3","author":"Di Marco Barros","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib191","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","article-title":"Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers","volume":"10","author":"Jeltsch-David","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib192","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","author":"Mike","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102892_bib193","doi-asserted-by":"crossref","first-page":"173","DOI":"10.55563\/clinexprheumatol\/x2g7rp","article-title":"Osteopontin: another piece in the systemic lupus erythematosus immunopathology puzzle","volume":"1","author":"Martin-Marquez","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib194","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"Update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib195","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"3","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib196","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"12","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib197","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nicl.2015.05.002","article-title":"A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus","author":"Ercan","year":"2015","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.jaut.2022.102892_bib198","article-title":"Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment","volume":"1","author":"Mackay","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2022.102892_bib199","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hbm.24837","article-title":"Different patterns of cerebral perfusion in SLE patients with and without neuropsychiatric manifestations","volume":"3","author":"Zhuo","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jaut.2022.102892_bib200","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41380-020-00907-z","article-title":"Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment","volume":"7","author":"Bonacchi","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jaut.2022.102892_bib201","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"5","author":"Weiner","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib202","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.21591","article-title":"Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study","volume":"6","author":"Zhang","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WCO.0000000000000822","article-title":"Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Mackay","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jaut.2022.102892_bib204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0961203318815299","article-title":"Screening for cognitive dysfunction in systemic lupus erythematosus: the montreal cognitive assessment questionnaire and the informant questionnaire on cognitive decline in the elderly","volume":"1","author":"Chalhoub","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.semarthrit.2019.03.004","article-title":"Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus","volume":"2","author":"Kwan","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib206","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.wnl.0000180938.69146.5e","article-title":"Results of intervention for lupus patients with self-perceived cognitive difficulties","volume":"8","author":"Harrison","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2022.102892_bib207","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/ard.2004.029926","article-title":"Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study","volume":"11","author":"Haupt","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib208","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"4","author":"Barile-Fabris","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/0961203303lu251oa","article-title":"Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)","volume":"1","author":"Stojanovich","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib210","first-page":"CD002265","article-title":"Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus","volume":"2","author":"Fernandes Moca Trevisani","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jaut.2022.102892_bib211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9343(99)80078-3","article-title":"Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus","volume":"1","author":"Neuwelt","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib212","first-page":"2178","article-title":"Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus","volume":"11","author":"Kur","year":"2006","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0961203309345749","article-title":"Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations?","volume":"2","author":"Bag","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib214","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12659\/AJCR.912875","article-title":"Acute unilateral vision loss due to optic neuropathy in a patient with systemic lupus erythematosus","author":"Heckman","year":"2019","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.jaut.2022.102892_bib215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/art.25052","article-title":"Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial","volume":"1","author":"Ginzler","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib216","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/ard.2005.046615","article-title":"Mycophenolate mofetil for lupus related myelopathy","volume":"7","author":"Mok","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib217","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0961203312440346","article-title":"Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide","volume":"10","author":"Jasmin","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2022.102892_bib218","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1007\/s00296-011-2130-5","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment","volume":"12","author":"Sanz","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102892_bib219","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"4","author":"Tokunaga","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib220","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.semarthrit.2011.06.004","article-title":"Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence","volume":"3","author":"Narvaez","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102892_bib221","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/rheumatology\/ker176","article-title":"Low-dose rituximab therapy for refractory thrombocytopenia in patients with systemic lupus erythematosus--a prospective pilot study","volume":"9","author":"Chen","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2022.102892_bib222","article-title":"Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares--a case control study","volume":"8","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2022.102892_bib223","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fmed.2020.00222","article-title":"Clinical efficacy of routinely administered belimumab on proteinuria and neuropsychiatric lupus","author":"Pluss","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jaut.2022.102892_bib224","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/mrcr\/rxab003","article-title":"Clinical efficacy of belimumab in patients with systemic lupus erythematosus and headache. A report of two cases","volume":"1","author":"Kodera","year":"2022","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.jaut.2022.102892_bib225","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","article-title":"Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials","volume":"11","author":"Manzi","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib226","first-page":"41","article-title":"Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre","volume":"1","author":"Camara","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib227","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5350960","article-title":"Therapeutic plasma exchange as management of complicated systemic lupus erythematosus and other autoimmune diseases","author":"Aguirre-Valencia","year":"2019","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib228","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/19420862.2015.1007810","article-title":"Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody","volume":"2","author":"Peng","year":"2015","journal-title":"mAbs"},{"key":"10.1016\/j.jaut.2022.102892_bib229","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"2","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2022.102892_bib230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"3","author":"Morand","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102892_bib231","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","article-title":"Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus","volume":"1","author":"Hasni","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2022.102892_bib232","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20953336","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis","author":"Peng","year":"2020","journal-title":"Ther. Adv. Musculoskelet Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib233","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/annrheumdis-2019-216563","article-title":"Rapamycin prevents the impairments of social recognition induced by anti-P antibody in a murine model","volume":"3","author":"Wang","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102892_bib234","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2016.08.019","article-title":"CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus","author":"Chalmers","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102892_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.573677","article-title":"Centrally acting angiotensin-converting enzyme inhibitor suppresses type I interferon responses and decreases inflammation in the periphery and the CNS in lupus-prone mice","author":"Nocito","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:17:28Z","timestamp":1778505448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":235,"alternative-id":["S0896841122001007"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102892","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric lupus erythematosus: Focusing on autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102892"}}